Measuring resistant-genotype transmission of malaria parasites: Challenges and prospects

Parasitology Research

Volumn 113, Issue 4, 2014, Pages 1481-1487

  Abdul Ghani, Rashad ^a   Farag, Hoda F ^b   Allam, Amal F ^b   Azazy, Ahmed A ^a,c  

^a SANA A UNIVERSITY   (Yemen)

^b ALEXANDRIA UNIVERSITY   (Egypt)

^c AL BAHA UNIVERSITY   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; ARTEMISININ; CHLOROQUINE;

ANTIMALARIAL DRUG RESISTANCE; ARTICLE; CELL DENSITY; DISEASE DURATION; DRUG TRANSPORT; GAMETOCYTE; GENOTYPE; IN VITRO STUDY; IN VIVO STUDY; MALARIA CONTROL; MALARIA FALCIPARUM; MATHEMATICAL MODEL; NONHUMAN; PARASITE PREVALENCE; PARASITE TRANSMISSION; PLASMODIUM; PRIORITY JOURNAL; RISK ASSESSMENT; TREATMENT DURATION;

ANIMALS; ANTIMALARIALS; DRUG RESISTANCE; GENOTYPE; HUMANS; MALARIA; MODELS, THEORETICAL; PLASMODIUM FALCIPARUM;

EID: 84897021899     PISSN: 09320113     EISSN: 14321955     Source Type: Journal    
DOI: 10.1007/s00436-014-3789-9     Document Type: Article

References (89)

1. Abdel-Wahab A et al (2002) Dynamics of gametocytes among Plasmodium falciparum clones in natural infections in an area of highly seasonal transmission. J Infect Dis 185:1838-1842 (Pubitemid 34615485)
2. Adjuik M, Babiker A, Garner P, Olliaro P, Taylor W, White N (2004) Artesunate combinations for treatment of malaria: meta-analysis. Lancet 363:9-17 (Pubitemid 38076919)
3. Ali E, Mackinnon MJ, Abdel-Muhsin AM, Ahmed S, Walliker D, Babiker HA (2006) Increased density but not prevalence of gametocytes following drug treatment of Plasmodium falciparum. Trans R SocTropMed Hyg 100:176-183 (Pubitemid 43024774)
4. Aneke SJ (2002) Mathematical modelling of drug resistant malaria parasites and vector populations. Math Methods Appl Sci 25:335-346
5. Arevalo-Herrera M et al (2011) Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America. Mem Inst Oswaldo Cruz 106(Suppl 1):202-211
6. Artzy-Randrup Y, Alonso D, Pascual M (2010) Transmission intensity and drug resistance inmalaria population dynamics: implications for climate change. PLoS One 5:e13588
7. Babiker HA, Schneider P (2008) Application of molecular methods for monitoring transmission stages of malaria parasites. Biomed Mater 3:034007
8. Babiker HA et al (1999) Detection of low level Plasmodium falciparum gametocytes using reverse transcriptase polymerase chain reaction. Mol Biochem Parasitol 99:143-148 (Pubitemid 29127193)
9. Babiker HA, Schneider P, Reece SE (2008) Gametocytes: insights gained during a decade of molecular monitoring. Trends Parasitol 24:525-530
10. Bacaer N, Sokhna C (2005) A reaction-diffusion system modeling the spread of resistance to an antimalarial drug. Math Biosci Eng 2:227-238
11. Baker DA (2010) Malaria gametocytogenesis. Mol Biochem Parasitol 172:57-65
12. Barnes KI, White NJ (2005) Population biology and antimalarial resistance: the transmission of antimalarial drug resistance in Plasmodium falciparum. Acta Trop 94:230-240 (Pubitemid 40720329)
13. Barnes KI et al (2008) Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria. J Infect Dis 197:1605-1613 (Pubitemid 351706492)
14. Bonnet S, Gouagna C, Safeukui I, Meunier JY, Boudin C (2000) Comparison of artificial membrane feeding with direct skin feeding to estimate infectiousness of Plasmodium falciparum gametocyte carriers to mosquitoes. Trans R Soc Trop Med Hyg 94:103-106 (Pubitemid 30116576)
15. Bousema JT et al (2003) Treatment failure of pyrimethamine-sulphadoxine and induction of Plasmodium falciparum gametocytaemia in children in western Kenya. Trop Med Int Health 8:427-230
16. Bousema JT et al (2004) Plasmodium falciparum gametocyte carriage in asymptomatic children in western Kenya. Malar J 3:18
17. Bousema JT et al (2006) Moderate effect of artemisinin-based combination therapy on transmission of Plasmodium falciparum. J Infect Dis 193:1151-1159
18. Buckling AG, Taylor LH, Carlton JM, Read AF (1997) Adaptive changes in Plasmodium transmission strategies following chloroquine chemotherapy. Proc Biol Sci 264:553-559
19. Buckling A, Ranford-Cartwright LC, Miles A, Read AF (1999) Chloroquine increases Plasmodium falciparum gametocytogenesis in vitro. Parasitology 118(Pt 4):339-346 (Pubitemid 29186944)
20. Butcher GA (1997) Antimalarial drugs and the mosquito transmission of Plasmodium. Int J Parasitol 27:975-987
21. Cammack N (2012) Exploiting malaria drug resistance to our advantage. Science 333:705-706
22. Carter R, Graves PM (1988) Gametocytes. In: Wernsdorfer WH, McGregor I (eds) Malaria: principles and practice of malariology. Churchill Livingstone, Edinburgh, pp 253-305
23. Cheeseman IH et al (2012) A major genome region underlying artemisinin resistance in malaria. Science 336:79-82
24. Chiyaka C, Garira W, Dube S (2009) Effects of treatment and drug resistance on the transmission dynamics ofmalaria in endemic areas. Theor Popul Biol 75:14-29
25. Cornelissen AW, Walliker D (1985) Gametocyte development of Plasmodium chabaudi in mice and rats: evidence for host induction of gametocytogenesis. ZParasitenkd 71:297-303 (Pubitemid 15051052)
26. de Roode JC, Culleton R, Bell AS, Read AF (2004) Competitive release of drug resistance following drug treatment of mixed Plasmodium chabaudi infections. Malar J 3:33
27. Dye C, Williams B (1997) Multigenic drug resistance among inbred malaria parasites. Proc Biol Sci 264:61-67
28. EnserinkM(2008)Malaria. Signs of drug resistance rattle experts, trigger bold plan. Science 322:1776
29. Gasasira AF et al (2003) Comparative efficacy of aminoquinoline- antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. Am J Trop Med Hyg 68:127-132 (Pubitemid 38240533)
30. Giha HA (2010) Artemisinin derivatives for treatment of uncomplicated Plasmodium falciparum malaria in Sudan: too early for too much hope. Parasitol Res 106:549-552
31. Giha HA, Elbashir MI, A-Elbasit IE, A-Gadir TM, ElGhazali G (2008) Bimodal transmission of cerebral malaria and severe malarial anemia and reciprocal co-existence of sexual and asexual parasitemia in an area of seasonal malaria transmission. Parasitol Res 103:81-85
32. Graves PM et al (1988) Measurement of malarial infectivity of human populations to mosquitoes in the Madang Area, Papua New Guinea. Parasitology 96(Pt 2):251-263
33. Gupta B, Awasthi G, Das A (2010) Malaria parasite genome scan: insights into antimalarial resistance. Parasitol Res 107:495-499
34. Hastings IM (1997) A model for the origins and spread of drug-resistant malaria. Parasitology 115(Pt 2):133-141
35. Hastings IM (2003) Malaria control and the evolution of drug resistance: an intriguing link. Trends Parasitol 19:70-73
36. Hastings IM, Watkins WM (2005) Intensity of malaria transmission and the evolution of drug resistance. Acta Trop 94:218-229 (Pubitemid 40720328)
37. Hogh B et al (1998) The differing impact of chloroquine and pyrimethamine/sulfadoxine upon the infectivity of malaria species to the mosquito vector. Am J Trop Med Hyg 58:176-182 (Pubitemid 28096223)
38. Jeffery GM, Eyles DE (1955) Infectivity to mosquitoes of Plasmodium falciparum as related to gametocyte density and duration of infection. Am J Trop Med Hyg 4:781-789
39. Jovani R, Sol D (2005) How predictable is the abundance of double gametocyte infections? Parasitol Res 97:84-86 (Pubitemid 41215277)
40. Kar PK, Dua VK, Gupta NC, Gupta A, Dash AP (2009) Plasmodium falciparum gametocytaemia with chloroquine chemotherapy in persistent malaria in an endemic area of India. Indian J Med Res 129:299-304
41. Klein EY, Smith DL, Boni MF, Laxminarayan R (2008) Clinically immune hosts as a refuge for drug-sensitive malaria parasites. Malar J 7:67
42. Koella JC, Antia R (2003) Epidemiological models for the spread of anti-malarial resistance. Malar J 2:3
43. Kremsner PG, Krishna S (2004) Antimalarial combinations. Lancet 364:285-294
44. Kumar N, Zheng H (1990) Stage-specific gametocytocidal effect in vitro of the antimalaria drug qinghaosu on Plasmodium falciparum. Parasitol Res 76:214-218 (Pubitemid 20116097)
45. Le Bras J, Durand R (2003) The mechanisms of resistance to antimalarial drugs in Plasmodium falciparum. Fundam Clin Pharmacol 17:147-153 (Pubitemid 36513205)
46. MackinnonMJ (2005) Drug resistance models for malaria. Acta Trop 94:207-217
47. Maeno Y et al (2008) A dried blood sample on filter paper is suitable for detecting Plasmodium falciparum gametocytes by reverse transcription polymerase chain reaction. Acta Trop 107:121-127
48. Markus MB (2012) Dormancy in mammalian malaria. Trends Parasitol 28:39-45
49. Mehlhorn H (ed) (2008) Encyclopedia of parasitology, 3rd edn. Springer, Heidlberg
50. Méndez F et al (2002) Determinants of treatment response to sulfadoxine-pyrimethamine and subsequent transmission potential in falciparum malaria. Am J Epidemiol 156:230-238 (Pubitemid 34811961)
51. Méndez F, Munoz A, Plowe CV (2006) Use of area under the curve to characterize transmission potential after antimalarial treatment. Am J Trop Med Hyg 75:640-644 (Pubitemid 46941268)
52. Méndez F et al (2007) Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes. Am J Trop Med Hyg 77:438-443 (Pubitemid 351844315)
53. Mita T, Tanabe K (2012) Evolution of Plasmodium falciparum drug resistance: implications for the development and containment of artemisinin resistance. Jpn J Infect Dis 65:465-475
54. Mita T, Tanabe K, Kita K (2009) Spread and evolution of Plasmodium falciparum drug resistance. Parasitol Int 58:201-209
55. Mockenhaupt FP et al (2005) Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana. Trop Med Int Health 10:901-908 (Pubitemid 41291231)
56. Nacher M et al (2002) Decreased hemoglobin concentrations, hyperparasitemia, and severe malaria are associated with increased Plasmodium falciparum gametocyte carriage. J Parasitol 88:97-101 (Pubitemid 34250637)
57. Nassir E et al (2005) Impact of genetic complexity on longevity and gametocytogenesis of Plasmodium falciparum during the dry and transmission-free season of eastern Sudan. Int J Parasitol 35:49-55 (Pubitemid 41556671)
58. Olliaro P (2005) Drug resistance hampers our capacity to roll back malaria. Clin Infect Dis 41(Suppl 4):S247-S257
59. Osorio L, Ferro BE, Castillo CM (2002) Effects of chloroquine and sulfadoxine/pyrimethamine on gametocytes in patients with uncomplicated Plasmodium falciparum malaria in Colombia. Mem Inst Oswaldo Cruz 97:1221-1223 (Pubitemid 135747602)
60. Ouedraogo AL et al (2009) Substantial contribution of submicroscopical Plasmodium falciparum gametocyte carriage to the infectious reservoir in an area of seasonal transmission. PLoS One 4:e8410
61. Paganotti GM et al (2006) Genetic complexity and gametocyte production of Plasmodium falciparum in Fulani andMossi communities in Burkina Faso. Parasitology 132(Pt 5):607-614
62. Peatey CL, Skinner-Adams TS, Dixon MW, McCarthy JS, Gardiner DL, Trenholme KR (2009) Effect of antimalarial drugs on Plasmodium falciparum gametocytes. J Infect Dis 200:1518-1521
63. Petersen I, Eastman R, Lanzer M (2011) Drug-resistant malaria: molecular mechanisms and implications for public health. FEBS Lett 585:1551-1562
64. Pongtavornpinyo W, Yeung S, Hastings IM, Dondorp AM, Day NP, White NJ (2008) Spread of anti-malarial drug resistance: mathematical model with implications for ACT drug policies. Malar J 7:229
65. Price RN et al (1996) Effects of artemisinin derivatives on malaria transmissibility. Lancet 347:1654-1658 (Pubitemid 26177386)
66. Puta C, Manyando C (1997) Enhanced gametocyte production in Fansidar-treated Plasmodium falciparum malaria patients: implications for malaria transmission control programmes. Trop Med Int Health 2:227-229 (Pubitemid 27153325)
67. Robert V, Molez JF, Trape JF (1996) Short report: gametocytes, chloroquine pressure, and the relative parasite survival advantage of resistant strains of falciparum malaria in west Africa. Am J Trop Med Hyg 55:350-351 (Pubitemid 26321845)
68. Robert V, Awono-Ambene HP, Le Hesran JY, Trape JF (2000) Gametocytemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine plus pyrimethamine. Am J Trop Med Hyg 62:210-216 (Pubitemid 30257580)
69. Ross R (1908) Report on the prevention of malaria in Mauritius. Waterlow and Sons Limited, London
70. Ross R (1911) The prevention of malaria, 2nd edn. JohnMurray, London
71. Schneider P et al (2006) (Sub)microscopic Plasmodium falciparum gametocytaemia in Kenyan children after treatment with sulphadoxine- pyrimethamine monotherapy or in combination with artesunate. Int J Parasitol 36:403-408
72. Schneweis S, Maier WA, Seitz HM (1991) Haemolysis of infected erythrocytes-a trigger for formation of Plasmodium falciparum gametocytes? Parasitol Res 77:458-460
73. Schröder W, Schmidt G (2008) Spatial modelling of the potential temperature-dependent transmission of vector-associated diseases in the face of climate change: main results and recommendations from a pilot study in Lower Saxony (Germany). Parasitol Res 103:S55-S63
74. Shekalaghe SA et al (2007) Submicroscopic Plasmodium falciparum gametocyte carriage is common in an area of low and seasonal transmission in Tanzania. Trop Med Int Health 12:547-553 (Pubitemid 46631150)
75. Smith DL, Ruktanonchai N (2010) Progress in modelling malaria transmission. Adv Exp Med Biol 673:1-12
76. Sokhna CS, Trape JF, Robert V (2001) Gametocytaemia in Senegalese children with uncomplicated falciparum malaria treated with chloroquine, amodiaquine or sulfadoxine+pyrimethamine. Parasite 8:243-250 (Pubitemid 33629563)
77. Sowunmi A, Fateye BA (2003) Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs. Trop Med Int Health 8:783-792 (Pubitemid 37108478)
78. Sowunmi A, Fateye BA, Happi TC, Gbotosho GO, Oduola AM (2003) Plasmodium falciparum gametocytaemia in Nigerian children: peripheral immature gametocytaemia as an indicator of a poor response to chloroquine treatment, and its relationship to molecular determinants of chloroquine resistance. Ann TropMed Parasitol 97:453-468 (Pubitemid 36898081)
79. Sutherland CJ et al (2002) Gambian children successfully treated with chloroquine can harbor and transmit Plasmodium falciparum gametocytes carrying resistance genes. Am J Trop Med Hyg 67:578-585 (Pubitemid 36014913)
80. Talman AM, Domarle O, McKenzie FE, Ariey F, Robert V (2004) Gametocytogenesis: the puberty of Plasmodium falciparum. Malar J 3:24
81. Targett G et al (2001) Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. J Infect Dis 183:1254-1259 (Pubitemid 32281565)
82. Tasman H, Soewono E, Sidarto KA, Syafruddin D, RogersWO (2009) A model for transmission of partial resistance to anti-malarial drugs. Math Biosci Eng 6:649-661
83. Taylor LH, Read AF (1997) Why so few transmission stages? Reproductive restraint by malaria parasites. Parasitol Today 13:135-140 (Pubitemid 27145370)
84. Taylor LH, Walliker D, Read AF (1997) Mixed-genotype infections of the rodent malaria Plasmodium chabaudi are more infectious to mosquitoes than single-genotype infections. Parasitology 115(Pt 2):121-132 (Pubitemid 27334566)
85. Tchuenche JM, Chiyaka C, Chan D, Matthews A, Mayer G (2011) A mathematicalmodel for antimalarial drug resistance.MathMed Biol 28:335-355
86. von Seidlein L et al (2000) Efficacy of artesunate plus pyrimethamine-sulphadoxine for uncomplicated malaria in Gambian children: a double-blind, randomised, controlled trial. Lancet 355:352-357
87. Waite H (1910) Mosquitoes and malaria. A study of the relation between the number of mosquitoes in a locality and the malaria rate. Biometrika 7:421-436
88. Wargo AR, Randle N, Chan BH, Thompson J, Read AF, Babiker HA (2006) Plasmodium chabaudi: reverse transcription PCR for the detection and quantification of transmission stage malaria parasites. Exp Parasitol 112:13-20 (Pubitemid 41796475)
89. World Health Organization (2010) Global report on antimalarial efficacy and drug resistance: 2000-2010. WHO, Geneva